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 CURRENTOPINION Mycobacterium chimaera infections associated
with heater–cooler units in cardiac surgery
Peter W. Schreiber and Hugo Sax
Purpose of review
Mycobacterium chimaera infections following cardiac surgery have been reported from an increasing
number of countries. These infections are characterized by a poor prognosis with a case fatality rate
around 50% despite treatment. Since the first description in 2013, our understanding has grown steadily.
Several outbreak investigations, case series, and experiments with heater–cooler units (HCUs) have been
published. This review summarizes the current knowledge.
Recent findings
M. chimaera transmission occurs during cardiopulmonary bypass via bioaerosols emitted from
contaminated HCU water systems. Manifestations of M. chimaera infection comprise endocarditis, vascular
graft infections, surgical site infections, and dissemination. So far, all cases were exposed to a single HCU
brand. Samples from the manufacturing site as well as clonality of M. chimaera strains isolated from HCUs
and patients suggest a contamination already at time of delivery representing the main source for the
outbreak. Nevertheless, HCU contamination in hospitals cannot be excluded.
Summary
Improved awareness of physicians of M. chimaera infection is crucial to prompt adequate diagnostic
workup in patients that have been exposed to HCU presenting with compatible symptoms. For risk
mitigation, strict separation between the air volume in contact with HCUs and critical clinical areas such as
operating rooms is essential.
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INTRODUCTION
Following an initial report on the outbreak investi-
gation of Mycobacterium chimaera infections after
open heart surgery, a steadily increasing number
of cases has been reported from several countries
[1–5]. This review addresses the current knowledge
of this global M. chimaera outbreak (Table 1).
M. chimaera, one of the latest members of the
Mycobacterium avium complex,was first described in
2004 [6]. Clinical reports identifiedM. chimaera as a
relatively rare cause of mycobacterial lung disease
[7]. Pulmonary infections caused byM. chimaera are
considered equally or less virulent than Mycobacte-
rium intracellulare [7,8]. More recently, M. chimaera
contamination has been identified in a number
of water-containing medical devices such as
heater–cooler units (HCUs) of various brands
[9
&&
,10,11
&
,12
&&
], extracorporeal membrane oxy-
genators [13], hyper–hypothermia systems feeding
cooling–warming blankets (personal communi-
cation P.W.S. and H.S.), and water fountains [9
&&
].
Owing to the association with M. chimaera infec-
tions, HCUs have come into the focus of infection
prevention and control teams, public health and
regulatory authorities, and the public. HCUs are a
functional part, yet standalone device, of the
extracorporeal circuit in surgery requiring cardio-
pulmonary bypass and responsible for temperature
regulation of blood and cardioplegia solution.
Water is used as heat transfer medium because of
its ideal properties for this purpose. Superfluous
heat is typically dissipated by a radiator and a fan.
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TRANSMISSION OF MYCOBACTERIUM
CHIMAERA DURING CARDIAC SURGERY
Historically, blood-borne infections originating
from the heart–lung machine were reported [14],
but in modern devices such leaks are very rare [15].
M. chimaera aerosolize from contaminated HCUs
and settle on surgical instruments, the open wound,
or directly on implant surfaces. InvasiveM. chimaera
infections have always occurred in association with
foreign materials such as prosthetic valves, grafts,
and wires [16
&
,17
&&
]. Following local biofilm for-
mation and replication, the bacteria disseminate
to bone marrow, liver, lungs, urinary tract, and
retina [17
&&
,18,19,20
&
]. However, recently several
studies report detecting M. chimaera in the water
system of LivaNova 3T (London, UK; formerly Sorin,
Germany; formerly Sto¨ckert) HCUs. M. chimaera
could also be detected in air samples or sedimen-
tation plates positioned in a roomwith running, but
not with nonrunningHCUs that were contaminated
[9
&&
,10,21
&&
]. Matching random amplified polymor-
phic DNA PCR patterns between water and corre-
sponding air samples confirmed M. chimaera
aerosolization further [9
&&
]. The hydrophobic nature
of cell membrane of mycobacteria results in exceed-
ingly high concentration of M. chimaera at water
surfaces and consequently, in bioaerosols [22]. A
feature of LivaNova 3T HCUs is the presence of
several fans, a large one for heat dissipation in the
lower part and smaller fans in the upper part of the
device to cool electronic components. One study
located aerosolization leakage and dissipation by an
upper fan [10]. Aerosol release has been traced to
leakage at the edge of the tank’s roof [12
&&
]. Exper-
iments using particle counters and smoke showed
that airflow and emitted bioaerosols of LivaNova
HCUs can disrupt the ultraclean air system designed
to protect the operating field [21
&&
].
Similar experiments with other HCU brands are
missing. Two experiments produced negative results
for the alternative hypothesis of direct transmission
via water-to-blood leakage through a defective oxy-
genator membrane. Intraoperative blood cultures of
32 patients with surgery using contaminated HCUs
did not produceM. chimaera [9
&&
]. A surrogate blood
circuit on prolonged extracorporeal circulation with
aM. chimaera contaminated HCU remained without
mycobacterial growth [10].
ORIGIN OF HEATER–COOLER UNIT
CONTAMINATION
Nontuberculousmycobacteria are known to colonize
hospitalwater systems [23] and contaminatemedical
devices. Hence, HCU contamination at the hospital
level cannot be excluded and other nontuberculous
mycobacteria besides M. chimaera might pose a
similar risk. Recently, contamination from tap water
with Mycobacterium abscessus resulting in HCU-
associated infections was reported [24
&&
].
Increasing evidence points toward a clonal
strain of M. chimaera related to one manufacturer’s
device being responsible for the majority of cases in
the current international outbreak. Already in
the first case report about two surgery-related
M. chimaera infections; a match between patient
isolates by random amplified polymorphic DNA
PCR was reported [25]. Current studies employed
whole genome sequencing to compare M. chimaera
patient strains and found them to be almost iden-
tical. A recent study described clonality among iso-
lates from HCUs and patients in Denmark and the
USA [26
&
]. In a cluster of 11 patients and samples
derived from five LivaNova 3T HCUs, a genetic
distance of maximal 38 single nucleotide polymor-
phisms across a core genome of circa five million
base pairs was seen [27]. Similarly, clonal M. chi-
maera isolates were described in HCU water samples
and one cardiac surgery patient from Australia and
New Zealand, also matching the 11 US patient
strains [5].
Until now, all cardiac surgery-associated cases
were associated with LivaNova 3T HCUs. One has to
consider, however, that devices of other manufac-
turers are much less prevalent [28]. Water samples
from the water pump assembly area at the LivaNova
production site as well as from factory-new HCUs
confirmed the presence of M. chimaera pointing to
a contamination at the time of production [16
&
].
In August 2014, M. chimaera positive environmen-
tal samples at the manufacturing site prompted
KEY POINTS
 Contamination of LivaNova 3T HCUs with M. chimaera
likely occurred during production, but contamination of
any HCU at the local level remains relevant.
 Airborne transmission of aerosolized M. chimaera from
HCU water to affected individuals during
cardiac surgery.
 M. chimaera infections are characterized by latency up
to 5.1 years, poor prognosis: curability
remains uncertain.
 HCU-associated M. chimaera infections are
likely underdiagnosed.
 Sustainable decontamination of contaminated HCUs
has not yet been established, necessitating strict
separation of HCU from operating room air.
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Table 1. Accumulating evidence on the Mycobacterium chimaera outbreak in cardiac surgery
Publication Origin Contribution to understanding the problem
Achermann et al. [25] Zurich, Switzerland Report on first two patients with identical strains by random
amplified polymorphic DNA PCR.
Sax et al. [9&&] Zurich, Switzerland Discovery of infectious source in HCU and aerosol transmission
pathway; other water reservoirs contaminated; hypothesis of
contamination from water system or at factory; description of four
additional patients.
Kohler et al. [17&&] Zurich, Switzerland Description of 10 Swiss, German, and Dutch patients.
Go¨tting et al. [10] Freiburg, Germany Confirmation of aerosolization, no evidence for water-to-blood
leakage through oxygenator in experiment with prolonged
simulated extracorporeal circulation.
Haller et al. [16&] Robert Koch Institute, European
Centre for Disease Prevention
and Control
Five cases from Germany, positive cultures at LivaNova/Sorin
factory.
Tan et al. [19] Rochester, USA Three cases in USA; two cases with ocular involvement as diagnostic
hint.
Garvey et al. [11&] Birmingham, UK Biofilm visualization; successful decontamination of HCU including
tubing change and two consecutive decontamination cycles.
Sommerstein et al. [21&&] Zurich, Switzerland Evidence for aerosol transmission with smoke video simulation,
particle counting, and sedimentation plates; the airstream
generated by HCU reaches the ultraclean ventilation system.
Sommerstein et al. [30] Bern, Switzerland Description of HCU placement outside operating room.
Schreiber et al. [31&&] Zurich, Switzerland Cohort study with five, in 2014 factory-new, LivaNova/Sorin HCUs,
monthly surveillance cultures for M. chimaera of HCU water and
exhaust air; reemergence of M. chimaera in HCU water samples
after circa six months despite intensified maintenance protocol; air
cultures remained without mycobacterial growth.
Perkins et al. [27] USA 11 patients, five HCUs, maximum of 38 SNPs distance with WGS.
Robinson et al. [29] Australia 10/15 HCU positive for M. chimaera; in WGS genetic relatedness
between isolates of 10 HCUs across four hospitals, but not related
to one cardiac surgery-associated case.
Struelens et al. [29] European Centre for Disease
Prevention and Control
Editorial to Robinson JO et al. and Truzinski FC et al. Description of
differences between HCU and extra-coporeal membrane
oxygenation devices in the context of M. chimaera contamination.
Trudzinski et al. [13] Germany 10 ECMOs, nine of 18 samples positive for M. chimaera but
negative air cultures and negative surface cultures; three patients
with bronchial colonization after ECMO support.
Sacco et al. IDCases 2017;7 : 1–
3
US Mayo Case report of 63 year old female; immune thrombocytopenia;
thrombocytopenia correlates with disease intensity.
Cai et al. Can J Anaesth.
2017;23 :513–516
US Mayo Case of 63 year old female with index surgery in 2010, symptom
start in 2015, misdiagnosis as amyloidosis and treated with
steroids.
Sommerstein, Schreiber et al.
Infect Control Hosp Epidemiol
2017;38 :103–8.
Switzerland/US Review summarizing current knowledge and providing preliminary
recommendations.
Baker et al. [24&&] USA Outbreak caused by Mycobacterium abscessus associated with
water system in phase 1 and HCU in phase 2; 22 patients with
extrapulmonary invasive disease caused by M. abscessus, nine
patients died within 60 days; decrease in cardiac surgery-
associated M. abscessus infections after intensified HCU
disinfection and use of sterile water with HCUs strongly suggests
that M. abscessus is also a problem with HCU technology.
Williamson et al. [5] Melbourne, Australia Description of a clonal M. chimaera lineage from Australia and
New Zealand in WGS; 43 samples from Sto¨ckert (now LivaNova)
3T and from five patients; one patient sample identical to two
HCU isolates of a center where the patient was re-operated
Nosocomial and healthcare related infections
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modifications in the manufacturing process [16
&
].
M. chimaera was also detected in HCUs from other
brands [18]. Additionally, M. chimaera was found in
extracorporeal membrane oxygenators and water
fountains [9
&&
,13].
EPIDEMIOLOGIC AND CLINICAL ASPECTS
M. chimaera invasive disease incidence seems rela-
tively low with 0.17–3 per 1000 procedures at risk
[12
&&
]. Data from the United Kingdom from 2007
to 2014 demonstrate an overall incidence of 0.39
cases per 10 000 person years with the highest inci-
dence in 2013 [12
&&
]. Contrasting the wide distri-
bution of LivaNova HCUs, little is known on the
true geographical distribution ofM. chimaera infec-
tions. So far, cardiac surgery-associated cases were
only reported from Switzerland, the Netherlands,
Germany [17
&&
], UK [12
&&
], USA [19], Australia [29],
and New Zealand [5].
The spectrum of infections caused by M. chi-
maera includes endocarditis, sternal, vascular graft,
and disseminated infections [17
&&
]. Prominent
clinical findings can be observed with ophthalmo-
logical examination [19,20
&
] and the dynamics of
retinal involvement might allow monitoring of
treatment response. Cardiac surgery-associated
M. chimaera infections have a poor prognosis and
sustained cure remains uncertain. In the largest
published case series to date, case fatality rate was
around 50% despite treatment with at least three
active antibiotics combined in many cases with
revision surgery [17
&&
]. M. chimaera still grew in
tissue samples after several months of targeted
antibiotic combination therapy consisting of clari-
thromycin, rifabutin, ethambutol, and transiently
quinolones. Typically, latency up to 5.1 years
(median, 21 months) between cardiac surgery and
manifest M. chimaera infection has been observed
[12
&&
]. Frequently reported symptoms include fever,
Table 1 (Continued )
Publication Origin Contribution to understanding the problem
Chand et al. [12&&] UK Case identification by national laboratory and hospital admissions
data linkage: 18 patients in 11 hospitals 2007–2015 (3 months -
5 year latency) of whom nine with fatal outcome, cohort study for
risk assessment; WGS patterns show cluster between probable
cases and 86% of Sorin (now LivaNova) HCU isolates. HCU
investigations: localization of aerosol release through breaches in
tanks of Sorin (now LivaNova) 3T HCUs; detection of M.
chimaera in three of six Maquet HCU 30, four of four Maquet
HCU 40, but negative air cultures.
Kanamori et al. Clin Infect Dis
2017 Feb 1;64 :343–6
UK Editorial to Chand M et al. 2017. Delineation of potential
advantages and disadavantages of notification of patients
exposed to a HCU.
Zweifel [20&] Zurich, Switzerland Case series of five patients from published Zurich case series
window to systemic; ‘eye as window to systemic infection’.
Hamilton et al. Water Research,
2017;1 : 310-26
US Review addressing the risk of exposure with nontuberculous
mycobacteria from water sources in healthcare settings.
Nguyen et al. J Thoracic
Cardiovasc Surg, in press
US Discussion of ethical aspects of the M. chimaera outbreak on the
background of cases at the Mayo clinic.
Stewardson et al. Med J Aust
2017;206 :132–5
Australia Review highlighting the relevance of the M. chimaera outbreak for
Australian physicians.
Svensson et al. [26&] Denmark 18/21 (86%) HCU positive for M. chimaera: 14/16 Sorin 3T (now
LivaNova) and 4/5 Maquet, but no associated patients in WGS
analysis, strain isolated from Maquet HCU was distinct from those
from Sorin HCU; Sorin strain nearly identical to isolates from US
and UK; description of preventive measures (encasing in one,
HCU repositioning in the operating room and more frequent
decontamination in two, and placement outside operating room
(preexisting) in two centers).
Bursle et al. Infection, Disease &
Health (2017) 22, 1e5
Australia Report on first case from Australia, WGS match between patient
isolate and HCU
ECMO, extracorporeal membrane oxygenators; HCU, heater–cooler units; SNP, single-nucleotide polymorphisms; WGS, whole genome sequencing;
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weight loss, and shortness of breath [17
&&
]. Lympho-
penia, thrombocytopenia, anemia, elevated creati-
nine, and transaminases as well as C-reactive protein
are often encountered [17
&&
]. Misdiagnosis is com-
mon. Notoriously, histology of granulomatosis has
resulted in misdiagnosis as sarcoidosis, leading to
immunosuppressive treatment with unfavorable
consequences.
PREVENTING TRANSMISSION
To guarantee protection against contaminated bio-
aerosols, HCU have been outplaced in an adjacent
room [10,30]. Notably, an ajar door may allow bio-
aerosols to float back into the operating room [10].
The maximum allowed HCU tubing length is a
limiting factor to this solution. Purpose-built air-
tight encasings for LivaNova 3T HCUs directly con-
nected to the ventilation system of the operating
room have been successfully produced [31
&&
]. This
solution required an individual technical assess-
ment of the overall air flow management to be well
tolerated, but if feasible, cost might be inferior to
those for architectural solutions.
HEATER–COOLER UNIT
DECONTAMINATION AND MAINTENANCE
Studies testing HCU decontamination and main-
tenance procedures either used solid media [10],
mycobacterial growth indicator tubes [29], or both
[9
&&
,31
&&
], and various water volumes, reflecting the
lack of a standard and limiting comparison.
In a recent report, water samples from a cohort
of five factory-new LivaNova 3T HCUs in use for
6 months tested positive for mycobacteria, mostly
M. chimaera under an intensified maintenance pro-
tocol including daily water changes [31
&&
]. All air
samples remained negative for M. chimaera, prob-
ably because of a low bacterial burden. Garvey et al.
[11
&
] published a report on successful decontamina-
tion of M. chimaera contaminated LivaNova 3T
HCUs. The authors used a comprehensive approach
withmechanical removal of biofilm, replacement of
HCU parts, and two consecutive peracetic acid dis-
infection cycles. Mycobacterial suppression for a
period of 3 months after initial decontamination
was achieved under intensified maintenance with
daily water changes using filtered tap water and
added hydrogen peroxide, and weekly peracetic
acid disinfection cycles. Sustainability must yet be
established.
DISCUSSION
The outbreak is yet another example of contami-
nation of a complex medical device and other
unintended consequences that has required an
international investigation and effort. Although
the extent of this outbreak is yet unknown, the
current global case count is relatively low when
compared to other causes of surgical site infections.
This rarity can be explained by a stochastic phenom-
enon or alternatively, by the alignment of several
safety breakdowns that are best illustrated by the
Swiss Cheese Model (Fig. 1). It must be assumed,
however, that many patients remain undiagnosed
or misdiagnosed because of insufficient physician
knowledge about this disease and likely, a lack of
understanding potential risks associated with such
complex equipment. Reactivation after years of
latency might occur as known with M. tuberculosis.
Case detection remains challenging because of
missing diagnostic tests in latency. Most guidelines
recommend targeting patients with prior HCU
exposure and unclear inflammatory disease, especi-
ally with granulomatous manifestations.
Various HCU brands have proven to harbor
M. chimaera, nontuberculous mycobacteria and ot-
her potential pathogens. Even if cases so far have
only been associated with LivaNova 3T, safety of
other models and brands has yet to be formally
established. Consequently, before proof of well tol-
erated HCU technology becomes available, the air
volume in contact with HCU must be controlled
either by encasing the unit or placing it in a separate
FIGURE 1. Swiss Cheese Model applied to Mycobacterium
chimaera infections in cardiac surgery. The swiss cheese
model was proposed by Dante Orlandella and James T.
Reason of the University of Manchester in 1990 to illustrate
that multiple failure modes must align to produce an
accident. Here we demonstrate a possible explanation why
so far only relatively few patients were infected despite the
global use of heater–cooler unit technology. HCU, heater–
cooler unit; OR, operating room.
Nosocomial and healthcare related infections
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room with controlled ventilation, especially if
proven contaminated with M. chimaera. Relying
entirely on negative mycobacterial HCU water
and air cultures might be risky until culture test
sensitivity is established.
The outbreak brings several lessons to the
medical community. First, the delayed outbreak
investigation and mitigation highlights a striking
mismatch between a global industry distributing
sophisticated technology widely from one factory
and the fractioned public health authority systems
reacting with delay. Second, only an elegant and
painstakingly thorough outbreak investigation by
several international groups revealed and identified
the aspects of this equipment that led to patient
harm. Third, airflow producing devices can disrupt
the genuine ventilation design and create micro-
biologic risks. Fourth, being an apparently irreplace-
able heat transport medium, water cannot be
maintained sterile in HCU and once established,
removing biofilm-associated nontuberculous myco-
bacteria seems uncertain. Fifth, nontuberculous
mycobacteria are to be added to the list of pathogens
in healthcare water and air safety to pair Legionella
spp. and Aspergillus sps. And finally, complex
medical equipment should be thoroughly tested
by a third party prior tomarket introduction, especi-
ally in its context of use often constituting a com-
plex system that notoriously produces unexpected
risk constellations, and permanently and proac-
tively monitored for unintended consequences.
CONCLUSION
By pure chance and a consequent investigation, an
inane patient safety breach was uncovered in the
sophisticated and high-stake environment of cardiac
surgery. This breach is best described by the Swiss
cheese model of aligning failure modes leading to
catastrophe (Fig. 1). The extent of the harm done has
yet tobe seen. Immediate action iswarrantedboth, to
identify infected individuals and have them benefit
from early treatment, and to prevent further infec-
tions by swift action. It would be desirable that forces
could be joined across research teams, authorities,
and industries globally to rapidly produce a well
tolerated alternative for intraoperative temperature
management in cardiac surgery.
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